SBIO
SBIO
About ALPS Medical Breakthroughs ETF
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the...
About ALPS Medical Breakthroughs ETF
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 CRNX | Crinetics Pharmaceuticals, Inc. | 4.62% | 114.54K | $9.58M |
 APGE | Apogee Therapeutics, Inc. | 4.34% | 67.29K | $9.01M |
 XENE | Xenon Pharmaceuticals Inc. | 3.43% | 104.96K | $7.11M |
 CGON | CG Oncology Inc. | 3.35% | 95.91K | $6.95M |
 DNTH | Dianthus Therapeutics, Inc. | 2.82% | 59.39K | $5.86M |
 TVTX | Travere Therapeutics, Inc. | 2.74% | 101.05K | $5.69M |
 ORKA | Oruka Therapeutics, Inc. | 2.67% | 65.57K | $5.54M |
 DFTX | Definium Therapeutics, Inc. | 2.50% | 118.59K | $5.18M |
 MANE | Veradermics, Incorporated | 2.41% | 45.33K | $4.99M |
 EWTX | Edgewise Therapeutics, Inc. | 2.33% | 117.09K | $4.83M |
 ACAD | ACADIA Pharmaceuticals Inc. | 2.29% | 185.99K | $4.74M |
 DNLI | Denali Therapeutics Inc. | 2.20% | 172.61K | $4.57M |
 RLAY | Relay Therapeutics, Inc. | 2.14% | 237.18K | $4.44M |
 DYN | Dyne Therapeutics, Inc. | 2.05% | 179.83K | $4.25M |
 NAMS | NewAmsterdam Pharma Company N.V. | 2.04% | 127.15K | $4.23M |
 GPCR | Structure Therapeutics Inc. | 1.92% | 77.31K | $3.99M |
 IDYA | IDEAYA Biosciences, Inc. | 1.67% | 95.54K | $3.45M |
 CLDX | Celldex Therapeutics, Inc. | 1.58% | 85.21K | $3.28M |
 VERA | Vera Therapeutics, Inc. | 1.56% | 78.09K | $3.24M |
 IRON | Disc Medicine, Inc. | 1.52% | 41.51K | $3.15M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Canada
Netherlands
United Kingdom
Belgium
China
Germany
Singapore
SwitzerlandSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Canada Netherlands United Kingdom Belgium China Germany Singapore SwitzerlandHoldings (Top 20)
CRNX
Crinetics Pharmaceuticals, Inc.
APGE
Apogee Therapeutics, Inc.
XENE
Xenon Pharmaceuticals Inc.
CGON
CG Oncology Inc.
DNTH
Dianthus Therapeutics, Inc.
TVTX
Travere Therapeutics, Inc.
ORKA
Oruka Therapeutics, Inc.
DFTX
Definium Therapeutics, Inc.
MANE
Veradermics, Incorporated
EWTX
Edgewise Therapeutics, Inc.
ACAD
ACADIA Pharmaceuticals Inc.
DNLI
Denali Therapeutics Inc.
RLAY
Relay Therapeutics, Inc.
DYN
Dyne Therapeutics, Inc.
NAMS
NewAmsterdam Pharma Company N.V.
GPCR
Structure Therapeutics Inc.
IDYA
IDEAYA Biosciences, Inc.
CLDX
Celldex Therapeutics, Inc.
VERA
Vera Therapeutics, Inc.
IRON
Disc Medicine, Inc.